DuPont falls on earnings, but investors might want to buy on weakness

The market didn't like DuPont's (DD) third-quarter earnings report, sending shares of the chemical giant down as much as three percent during Tuesday's session. This component of the Dow Jones Industrial Average ($INDU) easily beat Wall Street's profit estimate, but sales across all DuPont's businesses were down.

DuPont's stock has been a market beater so far this year, rising 37 percent to outpace the S&P 500 ($INX) by 15 percentage points. Perhaps today's stumble offers investors a chance to buy the blue chip on weakness. Shares go for just 16 times forward earnings, offering a discount of about 20 percent to the broader market. That's an intriguing relative valuation. Perhaps most attractive is DuPont's dividend. The share-price slide has boosted the yield to 4.8 percent.
Read Full Story

Markets

DJIA 25,080.50 -205.99 -0.81%
NASDAQ 7,136.39 -64.48 -0.90%
NIKKEI 225 21,803.62 -42.86 -0.20%
HANG SENG 26,103.34 448.91 1.75%
DAX 11,402.59 -9.94 -0.09%
USD (per EUR) 1.13 0.00 0.02%
JPY (per USD) 113.48 -0.08 -0.07%
GBP (per USD) 1.28 -0.02 -1.21%
USD (per CHF) 1.01 0.00 -0.05%